Stock listing
Frankfurt:0N6A TME Pharma N.V. Aktie
German listing (Frankfurt) of TME Pharma N.V. · home listing Euronext:ALTME
Follow TME Pharma N.V. into a list and get an email when it puts out news.
Share price · FWB:0N6A
€0.103 EUR -0.001 (-1.0%)
Close on Nov 17, 2026
- Day range
- €0.102 – €0.103 EURNov 17, 2026
- Market cap
- €9.78M EURAt the close on Nov 17, 2026 · price × 94.99M shares outstanding
- 52-week range
- €0.033 – €0.178 EURLowest and highest trades, Nov 18, 2025 – Nov 17, 2026
- Traded on an average day
- €18,266 EURMedian day 0 shares · 38 days with no trades · last 3 months, Aug 17, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:ALTME · Home | €0.106 EUR | -0.001 (-0.9%) | 835,044 | €0.107 | €0.107 | €0.104 | €0.107 | Close on Nov 17, 2026 |
| Frankfurt:0N6A | €0.103 EUR | -0.001 (-1.0%) | — | €0.103 | €0.103 | €0.102 | €0.104 | Close on Nov 17, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 6, 2026 · FWB:0N6A · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.108 | -0.003 | -2.7% | €0.098 | €0.108 | €0.097 | 0 | |
| €0.111 | +0.007 | +6.7% | €0.096 | €0.112 | €0.095 | 508,242 | |
| €0.104 | 0.000 | 0.0% | €0.100 | €0.106 | €0.100 | 508,242 | |
| €0.104 | -0.006 | -5.5% | €0.101 | €0.106 | €0.101 | 8,696 | |
| €0.110 | -0.018 | -14.1% | €0.111 | €0.116 | €0.110 | 7,634 | |
| €0.128 | +0.028 | +28.0% | €0.131 | €0.132 | €0.126 | 1,010,112 | |
| €0.100 | -0.016 | -13.8% | €0.131 | €0.132 | €0.099 | 3,225,242 | |
| €0.116 | -0.004 | -3.3% | €0.118 | €0.118 | €0.115 | 286,060 | |
| €0.120 | +0.004 | +3.4% | €0.103 | €0.120 | €0.103 | 0 | |
| €0.116 | -0.001 | -0.9% | €0.117 | €0.118 | €0.116 | 499,378 | |
| €0.117 | +0.007 | +6.4% | €0.098 | €0.119 | €0.098 | 675,876 | |
| €0.110 | +0.004 | +3.8% | €0.100 | €0.112 | €0.100 | 0 | |
| €0.106 | +0.001 | +1.0% | €0.093 | €0.107 | €0.093 | 0 | |
| €0.105 | 0.000 | 0.0% | €0.097 | €0.105 | €0.096 | 0 | |
| €0.105 | +0.001 | +1.0% | €0.098 | €0.105 | €0.097 | 0 | |
| €0.104 | +0.004 | +4.0% | €0.095 | €0.105 | €0.094 | 0 | |
| €0.100 | -0.004 | -3.8% | €0.092 | €0.101 | €0.092 | 0 | |
| €0.104 | -0.009 | -8.0% | €0.100 | €0.111 | €0.099 | 0 | |
| €0.113 | 0.000 | 0.0% | €0.101 | €0.113 | €0.100 | 0 | |
| €0.113 | -0.002 | -1.7% | €0.101 | €0.115 | €0.101 | 0 | |
| €0.115 | -0.006 | -5.0% | €0.119 | €0.119 | €0.114 | 300,198 | |
| €0.121 | -0.002 | -1.6% | €0.120 | €0.121 | €0.120 | 253,960 | |
| €0.123 | +0.012 | +10.8% | €0.114 | €0.132 | €0.114 | 0 | |
| €0.111 | +0.007 | +6.7% | €0.101 | €0.112 | €0.101 | 0 | |
| €0.104 | +0.002 | +2.0% | €0.093 | €0.106 | €0.093 | 0 | |
| €0.102 | 0.000 | 0.0% | €0.094 | €0.102 | €0.094 | 37,600 | |
| €0.102 | +0.001 | +1.0% | €0.091 | €0.102 | €0.090 | 0 | |
| €0.101 | 0.000 | 0.0% | €0.094 | €0.103 | €0.094 | 0 | |
| €0.101 | 0.000 | 0.0% | €0.095 | €0.103 | €0.095 | 0 | |
| €0.101 | 0.000 | 0.0% | €0.096 | €0.103 | €0.096 | 0 | |
| €0.101 | 0.000 | 0.0% | €0.094 | €0.105 | €0.094 | 198,910 | |
| €0.101 | -0.029 | -22.3% | €0.093 | €0.102 | €0.092 | 0 | |
| €0.130 | +0.022 | +20.4% | €0.108 | €0.131 | €0.107 | 500 | |
| €0.108 | +0.001 | +0.9% | €0.108 | €0.108 | €0.105 | 0 | |
| €0.107 | -0.008 | -7.0% | €0.114 | €0.115 | €0.107 | 100,000 | |
| €0.115 | +0.016 | +16.2% | €0.101 | €0.115 | €0.101 | 10,000 | |
| €0.099 | -0.012 | -10.8% | €0.099 | €0.101 | €0.099 | 0 | |
| €0.111 | +0.010 | +9.9% | €0.102 | €0.117 | €0.100 | 0 | |
| €0.101 | +0.002 | +2.0% | €0.097 | €0.102 | €0.096 | 0 | |
| €0.099 | -0.001 | -1.0% | €0.108 | €0.108 | €0.098 | 0 | |
| €0.100 | -0.005 | -4.8% | €0.106 | €0.107 | €0.100 | 1,171,140 | |
| €0.105 | -0.006 | -5.4% | €0.109 | €0.111 | €0.104 | 0 | |
| €0.111 | -0.008 | -6.7% | €0.117 | €0.117 | €0.111 | 0 | |
| €0.119 | +0.001 | +0.8% | €0.118 | €0.121 | €0.118 | 0 | |
| €0.118 | -0.006 | -4.8% | €0.123 | €0.124 | €0.118 | 0 | |
| €0.124 | +0.015 | +13.8% | €0.111 | €0.132 | €0.110 | 200 | |
| €0.109 | -0.009 | -7.6% | €0.119 | €0.119 | €0.109 | 0 | |
| €0.118 | -0.006 | -4.8% | €0.124 | €0.125 | €0.117 | 0 | |
| €0.124 | -0.006 | -4.6% | €0.134 | €0.134 | €0.123 | 0 | |
| €0.130 | -0.013 | -9.1% | €0.145 | €0.145 | €0.129 | 7,300 | |
| €0.143 | +0.002 | +1.4% | €0.140 | €0.143 | €0.131 | 10 | |
| €0.141 | -0.037 | -20.8% | €0.161 | €0.161 | €0.139 | 0 | |
| €0.178 | +0.033 | +22.8% | €0.115 | €0.178 | €0.115 | 379,126 | |
| €0.145 | -0.015 | -9.4% | €0.145 | €0.160 | €0.143 | 0 | |
| €0.160 | +0.074 | +86.0% | €0.160 | €0.160 | €0.080 | 0 | |
| €0.086 | -0.004 | -4.4% | €0.086 | €0.086 | €0.084 | 887,200 | |
| €0.090 | -0.009 | -9.1% | €0.099 | €0.099 | €0.089 | 0 | |
| €0.099 | +0.024 | +32.0% | €0.075 | €0.100 | €0.074 | 0 | |
| €0.075 | +0.004 | +5.6% | €0.074 | €0.075 | €0.073 | 0 | |
| €0.071 | +0.010 | +16.4% | €0.062 | €0.072 | €0.062 | 0 |
Splits
1 split · FWB:0N6A · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-100 | Consolidation |
- Ticker
- Frankfurt:0N6A
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 10, 2026
TME Pharma provides further details on the exclusive negotiation agreement with TMS Co., Ltd. for NOX-A12
Latest news
GLORIA Study Team Receives the 2026 German University Medicine Prize for Its Glioblastoma Research with CXCL12 Inhibitor NOX-A12
Nov 3, 2026
Closed €0.104 (-5.5%) on Nov 3, 2026
TME Pharma Publishes Its Semi Annual Results and Half-Year Report
Oct 30, 2026
Closed €0.128 (+28.0%) on Oct 30, 2026
TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd.
Oct 29, 2026
Closed €0.10 (-13.8%) on Oct 29, 2026
TME Pharma extends financial visibility by lengthening debt maturity to June 2028
Oct 26, 2026
Closed €0.116 (-0.9%) on Oct 26, 2026
TME Pharma CEO message
Sep 16, 2026
Closed €0.111 (+9.9%) on Sep 16, 2026
Message du CEO de TME Pharma
Sep 15, 2026
Closed €0.111 (+9.9%) on Sep 16, 2026
TME Pharma fait le point sur ses activités
Aug 23, 2026
Closed €0.16 (+86.0%) on Aug 24, 2026
Minutes of the TME Pharma Annual General Meeting
Jun 17, 2026
Closed €0.07 (-4.1%) on Jun 18, 2026
Compte-rendu de l’assemblée générale de TME Pharma
Jun 16, 2026
Closed €0.073 (-2.7%) on Jun 17, 2026
Financings
Bonds
Nov 17, 2025 · US$1.94M
Terms changed: €1.71M · Warrants at €0.1 for 24 months
Buyers: D.M. van den Ouden (29% of the new bond issue); Mr. van den Ouden (will be issued 4,980,000 warrants to subscribe for up to 4,980,000 common shares); Diede van den Ouden (CEO; with 2 Supervisory Board members holds 29% of the May and August 2025 bonds); Maurizio PetitBon (50,000.00 € debt cash purchase amount); Lee Schalop (20,000.00 € debt cash purchase amount)
Insiders: Holders who agreed in principle to a one-year extension are CEO Diede van den Ouden and 2 Supervisory Board members, holding 29% of the May and August 2025 bonds (face value €718,946)
Use of proceeds: Support ongoing operations while seeking partners to advance the NOX-A12 and NOX-E36 clinical programs
Announced May 21, 2025 · Update May 26, 2025 · Update May 27, 2025 · Terms changed Nov 17, 2025
Bonds
Nov 17, 2025 · US$584,413
Closed: €500,000 raised · Warrants at €0.11 for 21 months
Buyers: Diede van den Ouden (CEO; with 2 Supervisory Board members holds 29% of the May and August 2025 bonds); Maurizio PetitBon (50,044.00 € subscription price; 639,272 warrants)
Insiders: Holders who agreed in principle to a one-year extension are CEO Diede van den Ouden and 2 Supervisory Board members, holding 29% of the May and August 2025 bonds (face value €718,946)
Use of proceeds: R&D, treasury investment strategy and search for acquisitions and partnerships in profitable businesses
Announced Aug 25, 2025 · Closed Sep 1, 2025 · Terms changed Nov 17, 2025
Warrant exercise of new ordinary shares from exercise of Warrants Z
Jun 27, 2025
Closed: €249,396 raised · €0.2 a share
Decks
Investor Presentation (June 2025)
Investor deck · 48 slides · June 2025
Shareholder Meeting (June 2024)
Shareholder meeting · 36 slides · Jun 27, 2024
Investor Presentation (December 2023)
Investor deck · 45 slides · December 2023
Corporate Update (November 2023)
Corporate update · 16 slides · Nov 30, 2023
TME Pharma N.V. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 15 in the last 12 months · 34 in all · newest Nov 10, 2026 · oldest 2025
- Decks
- 14 decks · latest June 2025
Where TME Pharma N.V. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:ALTME · Home listing | Euronext | France | EUR |
| gettex:0N6A | gettex | Germany | EUR |
| LS Exchange:A3DMC3 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A3DMC3 | Lang & Schwarz | Germany | EUR |
| Turquoise:ALTMEP | Turquoise | United Kingdom | EUR |
| Dusseldorf:0N6A | Dusseldorf | Germany | EUR |
| Frankfurt:0N6A · This page | Frankfurt | Germany | EUR |
| Hamburg:0N6A | Hamburg | Germany | EUR |
| Munich:0N6A | Munich | Germany | EUR |
| Stuttgart:0N6A | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about TME Pharma N.V.